HEMATO Facility is GMP certified to provide the best in class clinically processed Adult Stem Cells for clinical and research purposes. It has the capability and continues to engage with global practitioners, researchers and labs to offer the latest advancements to hospitals, practitioners and patients in India. It offers a comprehensive service including medical logistics to pick up and drop the samples from and to the point of application with proper temperature management from ambient to those attained using dry-ice based transport.
Researchers generally agree that a stem cell should be able to do both,
Self-renew: divide into another stem cell, which means making an identical copy of itself; and
Differentiate: change into a variety of other cell types
Theoretically, stem cell research can treat any type of disease and there’s no limitation. Given that researchers may be able to study all cell types they have the potential to make breakthroughs in any disease.
Stem cells are potentiated as therapeutic tool in drug targeting and regenerative medicine-from curing various neurological diseases and malignancies to congenital diseases. These technological advancements have established stem cells as future of medicine. However, due to ethico-social limitations, the use of embryonic stem cells (ESCs) has been avoided, while physiological availability of adult stem cells (ASCs) and induced pluripotent stem cells (iPSCs) has gained appropriate preference.
Researchers and doctors are working with adult stem cells to - Increase understanding of how diseases occur; Generate healthy cells to replace diseased cells and this is emerging as a new domain of Regenerative Medicine; Test new drugs for safety and effectiveness. Before using investigational drugs in people, researchers can use some types of stem cells to test the drugs for safety and quality.
Naturally occurring stem cells throughout the body hold the key to unlocking the next generation of advances in Regenerative Medicine. It is the next chapter in organ transplantation and uses cells instead of donor organs, which are rather limited in supply. Its purpose is to promote the use of stem cells or their derivatives to repair diseased, dysfunctional or injured tissue. These stem cells are manipulated to specialize into specific types of cells, such as heart muscle cells, blood cells or nerve cells. The research is ongoing and there are 1000s of clinical trials under way in advanced phases of implementation. HEMATO MESEN
The field of Transplantation using HSCs has matured over the last 4-5 decades into a widely deployed practice. Advancements continue and use of HSCT for newer medical conditions is increasing rapidly. There is also an acceptance of Enrichment and Depletion of specific cell types for advanced formulations that benefit the patients. HEMATO HSCT